<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The use of clonospecific probes has recently been employed for the detection of <z:e sem="disease" ids="C0242596" disease_type="Neoplastic Process" abbrv="MRD">minimal residual disease</z:e> in B- and <z:hpo ids='HP_0006727'>T-cell acute lymphoblastic leukemias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, these methods are predicated upon the successful amplification of the V-D-J rearrangement in the genome of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells by the polymerase chain reaction (PCR) </plain></SENT>
<SENT sid="2" pm="."><plain>In order to determine whether the type of B-cell lymphoid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> influenced the rate of success of amplifying the region of the immunoglobulin heavy chain gene rearrangement in these lesions, we studied 41 morphologically and immunologically well characterized B-cell <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>DNA was extracted from frozen tissue of the <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:hpo ids='HP_0001909'>leukemias</z:hpo>, and subjected to PCR amplification using a 5' immunoglobulin heavy chain gene variable region consensus Framework 3 region (FR3) primer, and a 3' consensus primer for the immunoglobulin heavy chain joining region </plain></SENT>
<SENT sid="4" pm="."><plain>One or two distinct bands, representing the rearranged immunoglobulin heavy chain gene, were detected in six of six small non-cleaved cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, five of five small lymphocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, four of six <z:hpo ids='HP_0006721'>acute lymphoblastic leukemias</z:hpo>, four of six follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, three of six diffuse mixed small and large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, one of six diffuse large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and one of six <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>; <z:hpo ids='HP_0000001'>all</z:hpo> control cases of lymphocyte predominant <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (5/5) and reactive <z:hpo ids='HP_0002729'>follicular hyperplasia</z:hpo> (5/5) were negative </plain></SENT>
<SENT sid="5" pm="."><plain>We therefore conclude that the type of B-cell <z:hpo ids='HP_0002664'>neoplasm</z:hpo> influences the ability to detect immunoglobulin gene rearrangements by PCR with currently used consensus primers </plain></SENT>
</text></document>